This is the third and final part of MedicinMan interview with Sunil Attavar, CMD, Group Pharma and President, KDPMA MedicinMan: Are there any estimates of what the overall business impact will be in terms of revenues of pharma companies? Â At this moment it is very difficult to estimate the impact but it will not be…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
